CAS: 1233322-09-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | BI-69A11 REF: TM-T25150CAS: 1233322-09-2 | 96.97% | 46.00 €~369.00 € | Mon 10 Mar 25 |
 | (E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one REF: 3D-IZB32209CAS: 1233322-09-2 | Min. 95% | - - - | Discontinued product |
BI-69A11
CAS:1233322-09-2
BI-69A11 is a dual AKT/NFkB inhibitor, increasing colon cancer cell sensitivity to mda-7/IL-24.
Formula:
C25H16ClN3O2
Purity:
96.97%
Color and Shape:
Solid
Molecular weight:
425.87
Ref: TM-T25150
| 1mg | 46.00 € | ||
| 2mg | 57.00 € | ||
| 5mg | 82.00 € | ||
| 10mg | 96.00 € | ||
| 25mg | 180.00 € | ||
| 50mg | 259.00 € | ||
| 100mg | 369.00 € | ||
| 1mL*10mM (DMSO) | 93.00 € |
Estimated delivery in United States, on Monday 10 Mar 2025
![(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one](https://static.cymitquimica.com/products/3D/thumb/IZB32209.jpg)
(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one
CAS:1233322-09-2
(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one is a novel anticancer drug that is currently undergoing clinical trials. It has been …
Formula:
C25H16ClN3O2
Purity:
Min. 95%
Molecular weight:
425.9 g/mol
Ref: 3D-IZB32209
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
